Haywood analyst Neal Gilmer maintained a Hold rating on OrganiGram Holdings (OGI – Research Report) today and set a price target of $3.00. The company’s shares closed last Friday at $1.56.
According to TipRanks, Gilmer is an analyst with an average return of -18.0% and a 26.98% success rate. Gilmer covers the Consumer Cyclical sector, focusing on stocks such as Cresco Labs, Green Thumb Industries, and Rubicon Organics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for OrganiGram Holdings with a $3.06 average price target, representing a 96.15% upside. In a report released on July 14, Alliance Global Partners also maintained a Hold rating on the stock with a C$2.25 price target.
See Insiders’ Hot Stocks on TipRanks >>
OGI market cap is currently $124.1M and has a P/E ratio of -0.77.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
Read More on OGI:
